Novasep Appoints New President of Synthesis Business Unit
Novasep selects Thierry van Nieuwenhove as new president of the synthesis business unit.
Novasep, a supplier of manufacturing solutions to the life sciences industry, has appointed Thierry van Nieuwenhove as president of the synthesis business unit.
Van Nieuwenhove holds a Master's degree in chemistry and biochemistry from the Catholic University of Louvain, Belgium. Van Nieuwenhove joins Novasep from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, general manager, and member of the board.
Source: Novasep
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
